产品详情
Targets
Target | Value |
---|---|
AuroraA | ki: 8nM |
AuroraB | ki: 9nM |
VEGFR2 | ki: 44nM |
FLT3 | ki: 44nM |
CDK2/CyclinE | ki: 0.39μM |
CDK9/CyclinT | ki: 0.48μM |
p70S6K | ki: 0.54μM |
Src | ki: 0.82μM |
CDK4/CyclinD | ki: 1.09μM |
LCK | ki: 2.8μM |
CDK1/CyclinB | ki: >10μM |
CDK7/CyclinH | ki: >10μM |
Abl | ki: >10μM |
Akt | ki: >10μM |
CaMKII | ki: >10μM |
CK2 | ki: >10μM |
ERK2 | ki: >10μM |
GSK-3α | ki: >10μM |
GSK-3β | ki: >10μM |
PKA | ki: >10μM |
PKC | ki: >10μM |
SAPK2A(p38α) | ki: >10μM |
PLK1 | ki: >10μM |
In vitro (25°C) | DMSO | Warmed: 24 mg/mL (65.13 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 27.14 mL | 135.69 mL | 271.37 mL |
0.5 mM | 5.43 mL | 27.14 mL | 54.27 mL |
1 mM | 2.71 mL | 13.57 mL | 27.14 mL |
5 mM | 0.54 mL | 2.71 mL | 5.43 mL |
*The above data is based on the productmolecular weight 368.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10248 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 368.5 |
Formula | C18H20N6OS |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 693228-63-6 |
Synonyms | CYC-116 |
SMILES | CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4 |
产品标签
Product Questions
Product Questions
Vandetanib (ZD6474)
Vandetanib (ZD6474)是一种VEGFR和EGFR拮抗剂,是一种酪氨酸激酶抑制剂,对于HUVEC增殖,PC-9细胞和酪氨酸激酶活…
Telatinib (BAY 57-9352)
Telatinib (BAY 57-9352)是一种口服的血管内皮生长因子受体2和3(VEGFR2/3)和血小板衍生的生长因子受体β酪氨酸…
TSU-68 (Orantinib, SU6668)
TSU-68 (Orantinib,SU6668)在无细胞试验中具有8 nM的Ki对PDGFR自磷酸化的最大效力,但也强烈抑制Flk-1和FGFR1反磷酸…
BMS-690514
BMS-690514是一种有效的选择性表皮生长因子受体(EGFR),HER2和HER4抑制剂,以及VEGF受体激酶。
TPT-260 (Dihydrochloride)
TPT-260是噻吩硫脲衍生物。
Regorafenib (BAY 73-4506)
Regorafenib (BAY 73-4506)是一种多激酶抑制剂,IC50为17、40和69 nM c-KIT,VEGFR2,B-Raf。Regorafenib(BAY 73-4506)是一种…